Real-world Study of StimLabs Human Placental Membrane Tissue to Treat Hard-to-Heal Wounds

A Retrospective, Multi-center Real-world Study of StimLabs Human Placental Membrane Tissue Used for Treatment in Hard-to-Heal Wounds

This is a retrospective, multi-center observational study to assess real-world outcomes of StimLabs human placental membrane tissue used in the treatment of hard-to-heal wounds, including chronic ulcers, diabetic foot ulcers (DFUs), and venous leg ulcers (VLUs). The collection of retrospective real-world data provides a broad range of experiences related to patient healthcare and treatment.

Inclusion Criteria:

• Consecutive diabetic subjects that received a Relese product application during treatment between May 2023 and April 2025.

Exclusion Criteria:

• Subjects not receiving an initial Relese application during treatment.